Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplant for High-Risk Pediatric Sarcomas
NCT00043979Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2002
- Primary completion
- May 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic peripheral blood progenitor cells in Ewing sarcoma, alveolar rhabdomyosarcoma (ARMS), desmoplastic small round cell tumor (DSRCT), sponsored by National Cancer Institute. Started Sep 2002; status: completed.
02
Drugs
allogeneic peripheral blood progenitor cells
03
Conditions
Ewing sarcomaalveolar rhabdomyosarcoma (ARMS)desmoplastic small round cell tumor (DSRCT)
Beyond the preview
Go deeper on NCT00043979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043979.